Literature DB >> 15840045

The association between atherosclerotic risk factors and renal function in the general population.

Jacobien C Verhave1, Hans L Hillege, Johannes G M Burgerhof, Ron T Gansevoort, Dick de Zeeuw, Paul E de Jong.   

Abstract

BACKGROUND: Generalized atherosclerosis is increasingly recognized as an important cause of end-stage renal disease (ESRD). We questioned to what extent atherosclerotic risk factors determine renal function in the general population.
METHODS: We used baseline data of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study. A total of 8592 subjects, aged 28 to 75 years old, visited the outpatient clinic for blood pressure and anthropometric measurements, fasting blood sampling, and delivery of two 24-hour urine collections for creatinine clearance and albuminuria calculations. Design-based multivariate linear regression was used to estimate renal function.
RESULTS: In a multivariate model, male gender and body mass index (BMI) were associated with a higher renal function, while increasing diastolic blood pressure, serum triglycerides, use of antihypertensive or lipid-lowering medication were associated with a lower renal function. Age, systolic blood pressure, and plasma glucose showed an inverse U-shaped relationship with renal function. Cholesterol/high-density lipoprotein (HDL) ratio, smoking, and antidiabetic medication did not contribute to explain renal function. The atherosclerotic risk factors were related to renal function independently of albuminuria or C-reactive protein (CRP). Albuminuria and CRP itself were also related to renal function. Following gender and age, BMI, urinary albumin excretion (UAE), and plasma glucose had the strongest relation with renal function.
CONCLUSION: We conclude that differences in renal function in the general population are (partly) explained by various atherosclerotic risk factors. Some risk factors are associated with elevated filtration, some with an impaired filtration, and others with both a higher and a lower renal function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840045     DOI: 10.1111/j.1523-1755.2005.00296.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  22 in total

Review 1.  The clinical significance of hyperfiltration in diabetes.

Authors:  G Jerums; E Premaratne; S Panagiotopoulos; R J MacIsaac
Journal:  Diabetologia       Date:  2010-05-23       Impact factor: 10.122

2.  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Authors:  Harald Mischak; Bruce A Julian; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2007-07-10       Impact factor: 3.494

3.  Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease.

Authors:  Jan A Krikken; Ron T Gansevoort; Robin P F Dullaart
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

4.  White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study.

Authors:  Jun Hata; Masayo Fukuhara; Satoko Sakata; Hisatomi Arima; Yoichiro Hirakawa; Koji Yonemoto; Naoko Mukai; Takanari Kitazono; Yutaka Kiyohara; Toshiharu Ninomiya
Journal:  Hypertens Res       Date:  2017-09-07       Impact factor: 3.872

5.  Estimated GFR associates with cardiovascular risk factors independently of measured GFR.

Authors:  Ulla Dorte Mathisen; Toralf Melsom; Ole C Ingebretsen; Trond Jenssen; Inger Njølstad; Marit D Solbu; Ingrid Toft; Bjørn O Eriksen
Journal:  J Am Soc Nephrol       Date:  2011-03-31       Impact factor: 10.121

6.  The association between high-density lipoproteins and estimated glomerular filtration rate in patients without severe kidney disease.

Authors:  Domagoj Markovic; Gorana Trgo; Ingrid Prkacin; Damir Fabijanic; Vedran Kovacic
Journal:  Int Urol Nephrol       Date:  2018-03-28       Impact factor: 2.370

Review 7.  Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.

Authors:  Jochen Metzger; Peter B Luppa; David M Good; Harald Mischak
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

8.  Physical exercise, fasting glucose, and renal hyperfiltration in the general population: the Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6).

Authors:  Toralf Melsom; Ulla Dorte Mathisen; Britt-Ann Winther Eilertsen; Ole C Ingebretsen; Trond Jenssen; Inger Njølstad; Marit D Solbu; Ingrid Toft; Bjørn O Eriksen
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-23       Impact factor: 8.237

9.  Metabolic risk factors associated with serum creatinine in a non-diabetic population.

Authors:  Jens Kronborg; Trond Jenssen; Inger Njølstad; Ingrid Toft; Bjørn O Eriksen
Journal:  Eur J Epidemiol       Date:  2007-07-25       Impact factor: 8.082

10.  Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.

Authors:  N C den Hollander; D J Mulder; R Graaff; S R Thorpe; J W Baynes; G P A Smit; A J Smit
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.